BD (Becton, Dickinson and Company), a global leader in medical technology, has unveiled the BD Intraosseous (IO) Vascular Access System, designed to provide rapid vascular access during critical emergencies. This device enables swift delivery of fluids or medication through the bone marrow cavity when traditional intravenous (IV) access is challenging. The BD IO System caters to both adult and pediatric patients, featuring unique capabilities such as passive needle-tip safety to prevent needlestick injuries, rechargeable battery-powered operation, and five customizable needle lengths for diverse anatomical needs. Its advanced design allows placement after attaching the extension set, distinguishing it as the only device of its kind in the market.
Studies highlight that IO access has a high success rate of 93–97% among trained professionals, particularly in critical cases where blood pressure is undetectable, making it twice as effective as peripheral IV or central venous catheter placements. BD, with over 70,000 employees and a global presence, continues to pioneer solutions that enhance clinical efficiency, safety, and outcomes. By addressing key healthcare challenges through cutting-edge technology and collaboration, BD demonstrates its commitment to supporting frontline healthcare providers and improving emergency care worldwide.
